Form 4: Confluent CRO Sells Shares Under 10b5-1 Plan

Confluent's Chief Revenue Officer, Ryan Norris Mac Ban, sold a total of 3,768 Class A Common Stock shares in February 2026 under a pre-arranged 10b5-1 trading plan.

Summary

• Ryan Norris Mac Ban, Confluent's Chief Revenue Officer, reported transactions involving Class A Common Stock.
• On February 13, 2026, 1,655 shares of Class A Common Stock were sold at a price of $30.54 per share.
• On February 18, 2026, an additional 2,113 shares of Class A Common Stock were sold at a price of $30.61 per share.
• These sales were executed pursuant to a Rule 10b5-1 trading plan dated August 22, 2025.
• The beneficial ownership after the February 13, 2026 transaction was 392,276 shares, which included 1,398 shares purchased through the Issuer's employee stock purchase plan on the same date.
• Following the February 18, 2026 transaction, the reporting person's beneficial ownership stands at 390,163 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a concern, these sales were conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned liquidity event rather than a reaction to new material non-public information.

Positives

• The purchase of 1,398 shares through the employee stock purchase plan on February 13, 2026, indicates continued participation in company equity programs by the Chief Revenue Officer.

Negatives

• The sale of 3,768 shares by a Chief Revenue Officer represents a reduction in direct equity exposure to the company's stock, although mitigated by the pre-arranged 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that routine insider sales under a 10b5-1 plan are a common practice for executives to manage personal finances and diversify holdings, often pre-scheduled to avoid accusations of trading on material non-public information. The concurrent ESPP purchase suggests continued confidence in the company's long-term prospects.

Stakeholder Impact

• Shareholders: May observe a slight decrease in insider ownership, though this is largely mitigated by the pre-arranged nature of the 10b5-1 plan, suggesting no immediate negative implications for company performance.

Key Dates

Recommendation

The reported transactions are routine sales by a corporate officer under a pre-established 10b5-1 trading plan. Such planned sales are common for executive compensation and personal financial management and do not typically signal a change in the company's fundamental outlook. The concurrent purchase through an ESPP further supports a neutral stance. Therefore, a 'hold' recommendation is appropriate, as these transactions do not provide new material information to alter an existing investment thesis.

Keywords

Confluent, CFLT, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Revenue Officer, Employee Stock Purchase Plan